Physician profile
Michael Martynik
NPI 1972519072
$6,154.45
in general payments reported to CMS, 2019-2025
39 companies · $689 in 2025
The $689 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $839 · 2020: $774 · 2021: $1,208 · 2022: $1,459 · 2023: $732 · 2024: $455 · 2025: $689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,862 · Entertainment: $13.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,862.29 |
| Entertainment | $13.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,321.05 | 2019-2024 | Veozah, Myrbetriq |
| Janssen Biotech, INC. | $784.02 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $757.49 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $519.29 | 2019-2024 | |
| Boston Scientific Corporation | $369.25 | 2019-2025 | Watchman Flx, Rezum Generator |
| Merck Sharp & Dohme LLC | $275.32 | 2020-2025 | Keytruda, Welireg, Lynparza |
| Urovant Sciences INC | $252.52 | 2021-2022 | |
| Olympus America INC. | $212.57 | 2022-2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $157.28 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $149.18 | 2022 | |
| Myovant Sciences INC. | $107.59 | 2021-2022 | |
| Teleflex LLC | $106.06 | 2020-2025 | Urolift, Barrigel |
| Astrazeneca Pharmaceuticals LP | $100.85 | 2020-2022 | |
| Dentsply Ih INC. | $89.23 | 2019-2021 | |
| Abbvie INC. | $87.27 | 2019-2023 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Martynik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.